Oncological Outcome of Combining Cytoreductive Prostatectomy and Metastasis-Directed Radiotherapy in Patients with Prostate Cancer and Bone Oligometastases: A Retrospective Cohort Study

BACKGROUND: The current standard of care for metastatic prostate cancer (mPCa) is androgen deprivation therapy (ADT) with or without anti-androgen and chemotherapy. The aim of this study was to evaluate the efficacy and safety of a multimodal approach including local primary tumor therapy, metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Peng, Wu, Ziyu, Wang, Kunpen, Gao, Guojun, Zhuang, Min, Yan, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520542/
https://www.ncbi.nlm.nih.gov/pubmed/33061582
http://dx.doi.org/10.2147/CMAR.S270882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520542/
https://www.ncbi.nlm.nih.gov/pubmed/33061582
http://dx.doi.org/10.2147/CMAR.S270882

Ejemplares similares